The AACR-Women in Cancer Research Charlotte Friend Memorial Lectureship was established in 1998 in honor of renowned virologist and discoverer of the Friend virus, Dr. Charlotte Friend, for her pioneering research on viruses, cell differentiation and cancer. The lecture is intended to give recognition to an outstanding female or male scientist who has made meritorious contributions to the field of cancer research and who has, through leadership or by example, furthered the advancement of women in science.
The recipient of the award will receive an honorarium, give an award lecture during the AACR Annual Meeting 2020 in San Diego, California, and will be provided support for the winner and a guest to attend the AACR Annual Meeting 2020.
Candidacy is open to all cancer researchers who are affiliated with any institution involved in cancer research, cancer medicine or cancer-related biomedical science anywhere in the world. Such institutions include those in academia, industry or government.
The lectureship will be presented to an individual investigator.
Institutions or organizations are not eligible for the lectureship.
Nominations may be submitted by any individual, whether an AACR member or nonmember, who is currently or has previously been affiliated with any institution involved in cancer research, cancer medicine, or cancer-related biomedical science. Self-nominations are prohibited.
Nominators must maintain strict confidentiality of their nominations and all nominations must be submitted electronically to https://myaacr.aacr.org. Paper nominations will not be accepted.
See the Program Guidelines and Nomination Instructions for complete details.
Candidates will be considered by a Selection Committee of international cancer leaders appointed by the president of the AACR. After careful deliberations by the committee, its recommendations will be forwarded to the Executive Committee of the AACR for final consideration and decision. Selection of the winner will be made on the basis of the candidate's contributions to the field of cancer research and to the advancement of women in science. No regard will be given to age, race, gender, nationality, geographic location or religious or political views.